Meeting
2012 ASCO Annual Meeting
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma (MPM).
Authors
Lee M. Krug
Memorial Sloan-Kettering Cancer Center, New York, NY
Lee M. Krug , Antoinette J. Wozniak , Hedy Lee Kindler , Ronald Feld , Marianna Koczywas , Jose Luis Morero , Cristina P. Rodriguez , Helen J. Ross , Julie E. Bauman , Sergey V Orlov , John C. Ruckdeschel , Alain C. Mita , Luis Fein , Cristian Fernandez , Robert Hall , Takumi Kawabe , Sunil Sharma
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Mesothelioma
Clinical Trial Registration Number
NCT00700336
Citation
J Clin Oncol 30, 2012 (suppl; abstr 7029)
DOI
10.1200/jco.2012.30.15_suppl.7029
Abstract #
7029
Poster Bd #
21
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
A randomized phase II study adding axitinib to pemetrexed-cisplatin in patients with malignant pleural mesothelioma (MPM): Clinical results of a single-center trial.
First Author: Wieneke A. Buikhuisen
Poster
2018 ASCO Annual Meeting
SWOG S0905: A randomized phase II study of cediranib versus placebo in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma.
First Author: Anne S. Tsao
Poster
2017 ASCO Annual Meeting
ATOMIC-Meso: A randomized phase 2/3 trial of ADI-PEG20 or placebo with pemetrexed and cisplatin in patients with argininosuccinate synthetase 1-deficient non-epithelioid mesothelioma.
First Author: Peter Wojciech Szlosarek
Poster
2014 Genitourinary Cancers Symposium
Peculiar study: Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer.
First Author: Jae-Lyun Lee